Genertec Universal Medical Group Co (HKSE:02666) 3-Year EBITDA Growth Rate : -0.90% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genertec Universal Medical Group Co 3-Year EBITDA Growth Rate?

Genertec Universal Medical Group Co's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.84.

During the past 12 months, Genertec Universal Medical Group Co's average EBITDA Per Share Growth Rate was 4.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -0.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Genertec Universal Medical Group Co was 24.10% per year. The lowest was -0.90% per year. And the median was 18.40% per year.

Competitive Comparison of Genertec Universal Medical Group Co's 3-Year EBITDA Growth Rate

For the Credit Services subindustry, Genertec Universal Medical Group Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genertec Universal Medical Group Co's 3-Year EBITDA Growth Rate Distribution in the Credit Services Industry

For the Credit Services industry and Financial Services sector, Genertec Universal Medical Group Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Genertec Universal Medical Group Co's 3-Year EBITDA Growth Rate falls into.

Genertec Universal Medical Group Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Genertec Universal Medical Group Co (HKSE:02666) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Genertec Universal Medical Group Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Genertec Universal Medical Group Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Genertec Universal Medical Group Co (HKSE:02666) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Genertec Universal Medical Group Co Ltd (HKSE:02666) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

5UM:Germany

Address

8-1 Chongwenmenwai Street, 4th, 5th and 13th Floor, West Wing of Hademen Plaza, Dongcheng District, Beijing, CHN

Website

https://www.umcare.cn

Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The Group has two business segments; The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services, and The hospital group business comprises medical services, hospital, and healthcare management, import and export trade, and domestic trade of medical-related goods and life cycle management of equipment assets. Geographically, it derives a majority of its revenue from Mainland China.

Executives

Citic Capital Holdings Limited	2201 Interest of corporation controlled by you
Tong Yong Ji Shu Ji Tuan Xiang Gang Guo Ji Zi Ben You Xian Gong Si	2101 Beneficial owner
Zhong Guo Tong Yong Ji Shu Ji Tuan Kong Gu You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Cp Management Holdings Limited	2201 Interest of corporation controlled by you
Trustar Capital Holdings Limited	2201 Interest of corporation controlled by you
Sounda Properties Limited	2201 Interest of corporation controlled by you
Chu Mang Yee	2201 Interest of corporation controlled by you
Meta Group Limited	2201 Interest of corporation controlled by you
Sounda Hopson Technology Holdings Limited	2201 Interest of corporation controlled by you
Sounda Hopson Technology Investment Limited	2201 Interest of corporation controlled by you
Zhang Yichen	2201 Interest of corporation controlled by you
Citic Capital Partners Limited	2201 Interest of corporation controlled by you

Genertec Universal Medical Group Co (HKSE:02666) Headlines

No Headlines